Prevention & lipidsCross-sectional study

Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol

Eur J Prev CardiolPublished

  • Cross-sectional genetic association study
  • polygenic score
  • Million Veteran Program

Authors' conclusion

Genetically predicted Lp(a) is positively associated with coronary plaque severity independent of LDL-C, consistent with Lp(a) promoting atherogenesis. However, the effects of Lp(a) may be greater for progression of plaque to obstructive disease than for the initial development of non-obstructive plaque.

Study context

Population
Million Veteran Program participants who underwent invasive angiogram
Participants
18,927 vs 4,039
Exposure
Genetically predicted Lp(a) (polygenic score), with genetically predicted low-density lipoprotein cholesterol (LDL-C) for comparison
  • European ancestryn = 18,927
  • African ancestryn = 4,039
Outcome
Coronary artery plaque severity: normal, non-obstructive disease, one-vessel disease, two-vessel disease, three-vessel or left main disease

Main finding

As reported in the abstract

Coronary plaque severity
  • Consistent associations between genetically predicted Lp(a) and obstructive coronary plaque, effect sizes trending upward with increasingly severe disease
  • Associations independent of risk factors, clinically measured LDL-C and genetically predicted LDL-C
  • No strong or consistent evidence for an association between genetically predicted Lp(a) and non-obstructive plaque

Observational data: associations, not effects.

Original publication

Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol. Eur J Prev Cardiol. Published 19 August 2024. doi:10.1093/eurjpc/zwae271

Summarised from the published abstract; every number is checked against it